BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wiederhold T, Lee MF, James M, Neujahr R, Smith N, Murthy A, Hartwig J, Gusella JF, Ramesh V. Magicin, a novel cytoskeletal protein associates with the NF2 tumor suppressor merlin and Grb2. Oncogene 2004;23:8815-25. [PMID: 15467741 DOI: 10.1038/sj.onc.1208110] [Cited by in Crossref: 51] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Ries D, Meisterernst M. Control of gene transcription by Mediator in chromatin. Semin Cell Dev Biol 2011;22:735-40. [PMID: 21864698 DOI: 10.1016/j.semcdb.2011.08.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
2 Lee M, Beauchamp RL, Beyer KS, Gusella JF, Ramesh V. Magicin associates with the Src-family kinases and is phosphorylated upon CD3 stimulation. Biochemical and Biophysical Research Communications 2006;348:826-31. [DOI: 10.1016/j.bbrc.2006.07.126] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
3 Jeronimo C, Robert F. The Mediator Complex: At the Nexus of RNA Polymerase II Transcription. Trends in Cell Biology 2017;27:765-83. [DOI: 10.1016/j.tcb.2017.07.001] [Cited by in Crossref: 109] [Cited by in F6Publishing: 92] [Article Influence: 21.8] [Reference Citation Analysis]
4 Okada T, You L, Giancotti FG. Shedding light on Merlin's wizardry. Trends Cell Biol 2007;17:222-9. [PMID: 17442573 DOI: 10.1016/j.tcb.2007.03.006] [Cited by in Crossref: 82] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
5 Cui Y, Groth S, Troutman S, Carlstedt A, Sperka T, Riecken LB, Kissil JL, Jin H, Morrison H. The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling. Oncogene 2019;38:6370-81. [PMID: 31312020 DOI: 10.1038/s41388-019-0883-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
6 Huang C, Hsieh N, Li C, Weng Y, Liu H, Lee M. MED28 Regulates Epithelial-Mesenchymal Transition Through NFκB in Human Breast Cancer Cells: MED28, EMT, AND BREAST CANCER. J Cell Physiol 2017;232:1337-45. [DOI: 10.1002/jcp.25610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
7 Huang C, Chou Y, Hsieh N, Chen H, Lee M. MED28 regulates MEK1-dependent cellular migration in human breast cancer cells. J Cell Physiol 2012;227:3820-7. [DOI: 10.1002/jcp.24093] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
8 Conaway RC, Conaway JW. Origins and activity of the Mediator complex. Semin Cell Dev Biol 2011;22:729-34. [PMID: 21821140 DOI: 10.1016/j.semcdb.2011.07.021] [Cited by in Crossref: 75] [Cited by in F6Publishing: 76] [Article Influence: 6.8] [Reference Citation Analysis]
9 James MF, Lelke JM, Maccollin M, Plotkin SR, Stemmer-Rachamimov AO, Ramesh V, Gusella JF. Modeling NF2 with human arachnoidal and meningioma cell culture systems: NF2 silencing reflects the benign character of tumor growth. Neurobiol Dis 2008;29:278-92. [PMID: 17962031 DOI: 10.1016/j.nbd.2007.09.002] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
10 Huang C, Hsieh N, Pan M, Li C, Chou Y, Chiou Y, Lee M. Resveratrol and pterostilbene regulate MED28 (magicin/EG1) expression and cell growth in MCF7 human breast cancer cells. Journal of Functional Foods 2015;12:158-67. [DOI: 10.1016/j.jff.2014.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Lee M, Hsieh N, Huang C, Li C. All Trans -Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells: ALL TRANS -RETINOIC ACID, MED28, AND β-CATENIN SIGNALING. J Cell Physiol 2016;231:1796-803. [DOI: 10.1002/jcp.25285] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
12 Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR. Neurofibromatosis type 2. Lancet 2009;373:1974-86. [PMID: 19476995 DOI: 10.1016/S0140-6736(09)60259-2] [Cited by in Crossref: 320] [Cited by in F6Publishing: 111] [Article Influence: 24.6] [Reference Citation Analysis]
13 Hanemann CO, Bartelt-kirbach B, Diebold R, Kämpchen K, Langmesser S, Utermark T. Differential gene expression between human schwannoma and control Schwann cells. Neuropathol Appl Neurobiol 2006;32:605-14. [DOI: 10.1111/j.1365-2990.2006.00769.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.1] [Reference Citation Analysis]
14 Beyer KS, Beauchamp RL, Lee MF, Gusella JF, Näär AM, Ramesh V. Mediator subunit MED28 (Magicin) is a repressor of smooth muscle cell differentiation. J Biol Chem 2007;282:32152-7. [PMID: 17848560 DOI: 10.1074/jbc.M706592200] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
15 Kostrouchová M, Kostrouch D, Chughtai AA, Kaššák F, Novotný JP, Kostrouchová V, Benda A, Krause MW, Saudek V, Kostrouchová M, Kostrouch Z. The nematode homologue of Mediator complex subunit 28, F28F8.5, is a critical regulator of C. elegans development. PeerJ 2017;5:e3390. [PMID: 28603670 DOI: 10.7717/peerj.3390] [Reference Citation Analysis]
16 Spaeth JM, Kim NH, Boyer TG. Mediator and human disease. Semin Cell Dev Biol 2011;22:776-87. [PMID: 21840410 DOI: 10.1016/j.semcdb.2011.07.024] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 5.7] [Reference Citation Analysis]
17 Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A, Choy E, Hu D, Tamraz B, Pawlikowska L, Wassel-Fyr C, Huntsman S, Waliszewska A, Rossin E, Li R, Garcia M, Reiner A, Ferrell R, Cummings S, Kwok PY, Harris T, Zmuda JM, Ziv E; Health, Aging and Body Composition (Health ABC) Study. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am J Hum Genet 2007;80:716-26. [PMID: 17357077 DOI: 10.1086/513206] [Cited by in Crossref: 128] [Cited by in F6Publishing: 148] [Article Influence: 8.5] [Reference Citation Analysis]
18 Sagers JE, Beauchamp RL, Zhang Y, Vasilijic S, Wu L, DeSouza P, Seist R, Zhou W, Xu L, Ramesh V, Stankovic KM. Combination therapy with mTOR kinase inhibitor and dasatinib as a novel therapeutic strategy for vestibular schwannoma. Sci Rep 2020;10:4211. [PMID: 32144278 DOI: 10.1038/s41598-020-60156-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
19 James MF, Han S, Polizzano C, Plotkin SR, Manning BD, Stemmer-Rachamimov AO, Gusella JF, Ramesh V. NF2/merlin is a novel negative regulator of mTOR complex 1, and activation of mTORC1 is associated with meningioma and schwannoma growth. Mol Cell Biol 2009;29:4250-61. [PMID: 19451225 DOI: 10.1128/MCB.01581-08] [Cited by in Crossref: 190] [Cited by in F6Publishing: 107] [Article Influence: 14.6] [Reference Citation Analysis]
20 Kerr K, Qualmann K, Esquenazi Y, Hagan J, Kim DH. Familial Syndromes Involving Meningiomas Provide Mechanistic Insight Into Sporadic Disease. Neurosurgery 2018;83:1107-18. [PMID: 29660026 DOI: 10.1093/neuros/nyy121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
21 Borggrefe T, Yue X. Interactions between subunits of the Mediator complex with gene-specific transcription factors. Semin Cell Dev Biol 2011;22:759-68. [PMID: 21839847 DOI: 10.1016/j.semcdb.2011.07.022] [Cited by in Crossref: 81] [Cited by in F6Publishing: 85] [Article Influence: 7.4] [Reference Citation Analysis]
22 Lim JY, Kim H, Jeun S, Kang S, Lee K. Merlin inhibits growth hormone-regulated Raf–ERKs pathways by binding to Grb2 protein. Biochemical and Biophysical Research Communications 2006;340:1151-7. [DOI: 10.1016/j.bbrc.2005.12.122] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
23 Beauchamp RL, James MF, DeSouza PA, Wagh V, Zhao WN, Jordan JT, Stemmer-Rachamimov A, Plotkin SR, Gusella JF, Haggarty SJ, Ramesh V. A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas. Oncotarget. 2015;6:16981-16997. [PMID: 26219339 DOI: 10.18632/oncotarget.4858] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
24 Yin JW, Wang G. The Mediator complex: a master coordinator of transcription and cell lineage development. Development 2014;141:977-87. [PMID: 24550107 DOI: 10.1242/dev.098392] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 15.8] [Reference Citation Analysis]
25 Yu MA, Cho JG, Kim KI, Jo YJ, Sung JH, Yang HB, Park SG. Generation of med28 specific monoclonal antibodies. Monoclon Antib Immunodiagn Immunother 2015;34:30-5. [PMID: 25723281 DOI: 10.1089/mab.2014.0068] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
26 Manchanda N, Lyubimova A, Ho HY, James MF, Gusella JF, Ramesh N, Snapper SB, Ramesh V. The NF2 tumor suppressor Merlin and the ERM proteins interact with N-WASP and regulate its actin polymerization function. J Biol Chem 2005;280:12517-22. [PMID: 15699051 DOI: 10.1074/jbc.C400583200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
27 Beauchamp RL, Erdin S, Witt L, Jordan JT, Plotkin SR, Gusella JF, Ramesh V. mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition. J Biol Chem 2021;296:100157. [PMID: 33273014 DOI: 10.1074/jbc.RA120.014960] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 Giubellino A, Burke TR Jr, Bottaro DP. Grb2 signaling in cell motility and cancer. Expert Opin Ther Targets 2008;12:1021-33. [PMID: 18620523 DOI: 10.1517/14728222.12.8.1021] [Cited by in Crossref: 118] [Cited by in F6Publishing: 104] [Article Influence: 8.4] [Reference Citation Analysis]
29 Rangwala R, Banine F, Borg J, Sherman LS. Erbin Regulates Mitogen-activated Protein (MAP) Kinase Activation and MAP Kinase-dependent Interactions between Merlin and Adherens Junction Protein Complexes in Schwann Cells. Journal of Biological Chemistry 2005;280:11790-7. [DOI: 10.1074/jbc.m414154200] [Cited by in Crossref: 50] [Cited by in F6Publishing: 24] [Article Influence: 2.9] [Reference Citation Analysis]
30 Rodriguez PQ, Unnersjö-Jess D, Zambrano SS, Guo J, Möller-Hackbarth K, Blom H, Jahnukainen T, Ebarasi L, Patrakka J. Inactivation of mediator complex protein 22 in podocytes results in intracellular vacuole formation, podocyte loss and premature death. Sci Rep 2020;10:20037. [PMID: 33208756 DOI: 10.1038/s41598-020-76870-0] [Reference Citation Analysis]
31 Reuss D, von Deimling A. Hereditary tumor syndromes and gliomas. Recent Results Cancer Res. 2009;171:83-102. [PMID: 19322539 DOI: 10.1007/978-3-540-31206-2_5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
32 Yoon NK, Maresh EL, Elshimali Y, Li A, Horvath S, Seligson DB, Chia D, Goodglick L. Elevated MED28 expression predicts poor outcome in women with breast cancer. BMC Cancer 2010;10:335. [PMID: 20584319 DOI: 10.1186/1471-2407-10-335] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
33 Li L, Walsh RM, Wagh V, James MF, Beauchamp RL, Chang YS, Gusella JF, Hochedlinger K, Ramesh V. Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency. PLoS One 2015;10:e0140192. [PMID: 26445504 DOI: 10.1371/journal.pone.0140192] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
34 Bachir S, Shah S, Shapiro S, Koehler A, Mahammedi A, Samy RN, Zuccarello M, Schorry E, Sengupta S. Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis. Int J Mol Sci 2021;22:E690. [PMID: 33445724 DOI: 10.3390/ijms22020690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lee MF, Pan MH, Chiou YS, Cheng AC, Huang H. Resveratrol modulates MED28 (Magicin/EG-1) expression and inhibits epidermal growth factor (EGF)-induced migration in MDA-MB-231 human breast cancer cells. J Agric Food Chem 2011;59:11853-61. [PMID: 21942447 DOI: 10.1021/jf202426k] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 2.8] [Reference Citation Analysis]
36 Choi JW, Lee JY, Phi JH, Wang KC, Chung HT, Paek SH, Kim DG, Park SH, Kim SK. Clinical course of vestibular schwannoma in pediatric neurofibromatosis Type 2. J Neurosurg Pediatr 2014;13:650-7. [PMID: 24724714 DOI: 10.3171/2014.3.PEDS13455] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 3.1] [Reference Citation Analysis]
37 Hassanudin SA, Ponnampalam SN, Amini MN. Determination of genetic aberrations and novel transcripts involved in the pathogenesis of oligodendroglioma using array comparative genomic hybridization and next generation sequencing. Oncol Lett 2019;17:1675-87. [PMID: 30675227 DOI: 10.3892/ol.2018.9811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
38 Carroll SL. Molecular mechanisms promoting the pathogenesis of Schwann cell neoplasms. Acta Neuropathol. 2012;123:321-348. [PMID: 22160322 DOI: 10.1007/s00401-011-0928-6] [Cited by in Crossref: 71] [Cited by in F6Publishing: 57] [Article Influence: 6.5] [Reference Citation Analysis]
39 Scoles DR. The merlin interacting proteins reveal multiple targets for NF2 therapy. Biochim Biophys Acta 2008;1785:32-54. [PMID: 17980164 DOI: 10.1016/j.bbcan.2007.10.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 30] [Article Influence: 0.5] [Reference Citation Analysis]
40 Poss ZC, Ebmeier CC, Taatjes DJ. The Mediator complex and transcription regulation. Crit Rev Biochem Mol Biol 2013;48:575-608. [PMID: 24088064 DOI: 10.3109/10409238.2013.840259] [Cited by in Crossref: 226] [Cited by in F6Publishing: 211] [Article Influence: 25.1] [Reference Citation Analysis]